Ventricular Tachycardia clinical trials

Explore recruiting ventricular tachycardia clinical trials.

Recruiting ventricular tachycardia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ventricular Tachycardia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Investigator-Initiated Prospective Randomized Open-Label Blinded-Endpoint Crossover Trial Comparing the Effect and Safety of Flecainide and Metoprolol versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse (FLECAPRO).

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 2A, INVESTIGATOR AND SUBJECT BLINDED, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a Trial to Investigate Safety, Tolerability and Exploratory Clinical Efficacy of AGP100 in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Early ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy

Poland

Therapeutic use (Phase IV) EU CTIS Study details

A PHASE 2, DOUBLE-BLIND, REPEAT-DOSE, PLACEBO-CONTROLLED CROSSOVER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

Netherlands, Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Carvedilol vs. flecainida clinical trial in idiopathic ventricular arrhythmias.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Ventricular Tachycardia trials by city

Ventricular Tachycardia in Toronto Ventricular Tachycardia in Vancouver Ventricular Tachycardia in Montreal Ventricular Tachycardia in Calgary Ventricular Tachycardia in Edmonton Ventricular Tachycardia in Ottawa Ventricular Tachycardia in Winnipeg Ventricular Tachycardia in Quebec City Ventricular Tachycardia in Hamilton Ventricular Tachycardia in Kitchener Ventricular Tachycardia in London Ventricular Tachycardia in Halifax Ventricular Tachycardia in New York Ventricular Tachycardia in Los Angeles Ventricular Tachycardia in Chicago Ventricular Tachycardia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease